Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

An experimental medicine from Vera Therapeutics significantly reduced levels of toxic protein in the urine of patients with ...

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.

Two companies trying to develop psychedelic medicines make a merger deal as the Trump administration has expressed support ...

The relentless drumbeat of cuts to U.S. government research and disease prevention have devastated tens of thousands of ...

Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, expanding its immunology pipeline ...

In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new ...